Atlas Trials

A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder

Clinical trial NCT02905227 · COMPLETED

Trial details

NCT number
NCT02905227
Sponsor
Acorda Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2016-09-01
Primary completion
2016-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.